FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for a generic extended-release dexmethylphenidate hydrochloride product (Par Health USA, LLC) for attention-deficit/hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (dexmethylphenidate hydrochloride extended-release)

Snippet

SUPPL AP for DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (DEXMETHYLPHENIDATE HYDROCHLORIDE)